Intrarosa 6.5 mg (Prasterone OVULE) 6.5 MG

Prasterone, the active ingredient in Intrarosa 6.5 mg, is a manmade form of dehydroepiandrosterone (DHEA). Once administered vaginally, prasterone is converted into active sex hormones, including estrogen and testosterone, in the vaginal tissues. This process helps restore the vaginal epithelium, improving lubrication and elasticity, which alleviates symptoms of vulvar and vaginal atrophy.

The usual dose of Intrarosa 6.5 mg is one vaginal insert placed into the vagina every day at bedtime. The prescriber will determine the appropriate dosage and duration of treatment based on the individual's needs and response to the medication.

Intrarosa 6.5 mg should not be used by women who are pregnant or breastfeeding. The medication is specifically indicated for postmenopausal women and is not recommended for use during pregnancy or while nursing due to potential risks to the developing fetus or infant.

To order Intrarosa 6.5 mg from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then reply with pricing, availability, shipping, and the necessary import paperwork.

Intrarosa 6.5 mg is the only vaginal non-estrogen treatment approved for moderate to severe painful sex due to menopause. Unlike estrogen-based therapies, it does not carry the same risks associated with estrogen use, making it a suitable option for women who cannot or prefer not to use estrogen treatments.

Intrarosa 6.5 mg should be stored at room temperature away from moisture and heat. Each applicator is for one-time use only. Empty your bladder and wash your hands before handling the vaginal insert and applicator. Use only the applicator supplied with the medication to insert the vaginal insert.

Intrarosa 6.5 mg is administered vaginally using the applicator provided with the medication. The usual dose is one insert placed into the vagina every day at bedtime. Follow the instructions provided by your healthcare provider and the medication guide for proper administration.

The most serious risks associated with Intrarosa 6.5 mg include allergic reactions, such as rash, itching, swelling, severe dizziness, or trouble breathing. Additionally, women with a history of breast cancer should avoid using this medication, as prasterone is converted to estrogen, which is not recommended for women with a history of breast cancer.

Intrarosa 6.5 mg should not be used by women who are allergic to prasterone or have unexplained vaginal bleeding that has not been checked by a healthcare provider. It is also not recommended for women who are pregnant or breastfeeding, as well as those with a history of breast cancer.